Tsuyoshi Fujita to Secondary Prevention
This is a "connection" page, showing publications Tsuyoshi Fujita has written about Secondary Prevention.
Connection Strength
0.037
-
Sanuki T, Fujita T, Kutsumi H, Hayakumo T, Yoshida S, Inokuchi H, Murakami M, Matsubara Y, Kuwayama H, Kawai T, Miyaji H, Fujisawa T, Terao S, Yamazaki Y, Azuma T. Rabeprazole reduces the recurrence risk of peptic ulcers associated with low-dose aspirin in patients with cardiovascular or cerebrovascular disease: a prospective randomized active-controlled trial. J Gastroenterol. 2012 Nov; 47(11):1186-97.
Score: 0.023
-
Ueshima K, Fukami K, Hiramori K, Hosoda S, Kishida H, Kato K, Fujita T, Tsutani K, Sakuma A. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study. Am Heart J. 2004 Aug; 148(2):e8.
Score: 0.014